|
TECHNOLOGY LICENSING
BioZone has four novel drug delivery technology
platforms, and one new drug candidate, that are broadly applicable
to multiple drugs, diseases, and dosage forms, including injectable,
topical, and oral applications. The development of therapeutic drugs
with BioZone's patented technology platforms may result in products
that have better efficacy, fewer side effects, and more convenient
administration.
BioZone Delivery Platform Advantages:
- Addresses delivery challenges of therapeutic drugs
-
May improve therapeutic benefits
-
Enhance efficacy
- Reduce side effects
- Provide faster and more convenient administration
-
Results in easy, ready-to-use formulations
-
Has broad applicability to multiple drugs and diseases
-
May be applied to a number of dosage forms, including injectable and oral applications
BioZone's Drug Delivery Platforms Available for License are:
- QuSomes™ - Injectable delivery with long circulating liposomes
Topical delivery with improved dermal penetration
- HyperSorb™ - Oral delivery in gel caps of liposomes for improved bioavailability
- LipoPhoresis™ - Topical delivery of liposomes with iontophoresis
- LipoSpray™ - Transmucosal delivery of drugs and supplements
- Other Technologies Available for License: Inflacin, nonsteroidal anti-inflammatory
Contents Copyright © 2004, BioZone Laboratories, Inc. all rights reserved
Web Design: Best Impression
|